ACA Issue Briefs provide rapid reaction to breaking arms control events and analyze key nuclear/chemical/biological/conventional arms issues. They are available for quotation by the media.
In nuclear negotiations, as in medicine, the first principle is: "Do no harm." Yet a bill authored by Sen. Robert Menendez (D-NJ) and co-sponsored by 58 of his colleagues, threatens to pull the plug on the patient just as the Iran nuclear negotiations are entering their most delicate phase.
The "Iran Nuclear Weapon Free Act" (S. 1881), introduced in the Senate on December 19 by Sens. Menendez (D-N.J.) and Kirk (R-Ill.), threatens to derail the breakthrough agreement that Iran and the P5+1 reached in Geneva on November 24 that will pause Iran's most worrisome nuclear activities in exchange for limited and reversible sanctions relief.
After years of on-and-off negotiations, the latest round of P5+1 (China, France, Russia, the United Kingdom, the United States, plus Germany) talks with Iran has finally yielded an important breakthrough: a "first-phase" deal to constrain Iran's nuclear potential and to "reach a mutually agreed long-term comprehensive solution that would ensure that Iran's nuclear programme will be exclusively peaceful."
The National Defense Authorization Act (S. 1197) is on the Senate floor, and there may be debate on how much latitude the President should have when seeking to reduce excess U.S. nuclear forces. Some will argue that any future nuclear reductions can only occur via a formal treaty; others will counter that informal approaches should also be an option. There is an obvious, bipartisan answer: Current and future presidents should have as much flexibility as previous presidents, both Republicans and Democrats.
After three days of intense, talks in Geneva Nov. 7-9, the P5+1 (China, France, Russia, the United Kingdom, the United States, plus Germany) and Iran came close to a breakthrough, "first phase" deal that would verifiably halt the progress of Iran's nuclear program, and at the same time increase International Atomic Energy Agency monitoring capabilities on its nuclear projects in exchange for limited, reversible sanction relief.
While much of the world's attention will remained focused on Iran's negotiations with six world powers over its nuclear program, Iran will meet with the International Atomic Energy Agency (IAEA) in Vienna on October 28, to continue talks over the agency's approach to investigating Tehran's alleged weapons-related nuclear activities.
The United States and its P5+1 partners--China, France, Russia, the United Kingdom and Germany--will resume negotiations with Iran on October 15-16 in Geneva to seek a lasting resolution to the high-stakes standoff over Iran's increasingly capable nuclear program.
The large-scale use of chemical weapons (CW) against rebel-controlled areas outside Damascus on August 21 requires a strong international response to help ensure that further such attacks are not launched ever again--in Syria or elsewhere.
By mid-September, P5+1 diplomats (from the United States, Britain, France, China, Russia, and Germany) will likely resume talks aimed at resolving concerns about Iran's nuclear program with President Hassan Rouhani's new negotiating team. The talks represent an important opportunity to finally reach a deal that limits Iran's most worrisome uranium enrichment activities, obtains more extensive inspections to guard against a secret weapons program, and shows Iran a path toward phasing out international sanctions.
President Obama announced on June 19 in Berlin that a new review of U.S. nuclear deterrence requirements found that "we can ensure the security of America and our allies, and maintain a strong and credible strategic deterrent, while reducing our deployed strategic nuclear weapons by up to one-third" below the limits established by the 2010 New START Treaty. "And," the President added, "I intend to seek negotiated cuts with Russia to move beyond Cold War nuclear postures."